Blood pressure targets, medication considerations and special concerns in elderly hypertension III: Focus on stroke and neurodegenerative disorders

Controlling hypertension has become an important issue in the elderly population in whom neurological comorbidities are highly prevalent. Most of the large-scale trials focusing on hypertension management in older populations have excluded patients with comorbid neurological disorders. However, this...

Full description

Saved in:
Bibliographic Details
Main Authors: Cheng-Hsuan Li, Sung-Ju Hsueh, Li-Kai Tsai, Wei-Hung Chang, Shao-Yi Cheng, Hao-Min Cheng, Chih-Fan Yeh, Yen-Hung Lin, Hsin-Hsi Tsai
Format: Article
Language:English
Published: Elsevier 2025-07-01
Series:Journal of the Formosan Medical Association
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0929664625000087
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849717248204210176
author Cheng-Hsuan Li
Sung-Ju Hsueh
Li-Kai Tsai
Wei-Hung Chang
Shao-Yi Cheng
Hao-Min Cheng
Chih-Fan Yeh
Yen-Hung Lin
Hsin-Hsi Tsai
author_facet Cheng-Hsuan Li
Sung-Ju Hsueh
Li-Kai Tsai
Wei-Hung Chang
Shao-Yi Cheng
Hao-Min Cheng
Chih-Fan Yeh
Yen-Hung Lin
Hsin-Hsi Tsai
author_sort Cheng-Hsuan Li
collection DOAJ
description Controlling hypertension has become an important issue in the elderly population in whom neurological comorbidities are highly prevalent. Most of the large-scale trials focusing on hypertension management in older populations have excluded patients with comorbid neurological disorders. However, this population requires special considerations, as the benefits of antihypertensive agents are mostly uncertain and there is a higher risk of adverse events. In this review article, we discuss current evidence regarding the management of elderly patients with hypertension and common neurological disorders, including stroke and neurodegenerative diseases.In elderly patient with a history of stroke, the blood pressure management strategy is generally similar to that for young patients, however the benefits of stroke prevention from blood pressure control are less significant. For patients with neurodegenerative disorders such as cognitive dysfunction and Parkinson's disease, achieving adequate blood pressure control may be beneficial in reducing cardiovascular risks, although the higher risk of adverse events from antihypertensive treatment may offset some of these benefits. Special considerations for factors such as orthostatic hypotension, risk of falls, polypharmacy, and significant drug-drug interactions are required but frequently neglected in clinical practice. More efforts are warranted to determine the optimal treatment strategy for elderly populations with neurological disorders.
format Article
id doaj-art-e2bf0d53bfcb4cde893afba8ecc97382
institution DOAJ
issn 0929-6646
language English
publishDate 2025-07-01
publisher Elsevier
record_format Article
series Journal of the Formosan Medical Association
spelling doaj-art-e2bf0d53bfcb4cde893afba8ecc973822025-08-20T03:12:43ZengElsevierJournal of the Formosan Medical Association0929-66462025-07-01124S55S6210.1016/j.jfma.2025.01.008Blood pressure targets, medication considerations and special concerns in elderly hypertension III: Focus on stroke and neurodegenerative disordersCheng-Hsuan Li0Sung-Ju Hsueh1Li-Kai Tsai2Wei-Hung Chang3Shao-Yi Cheng4Hao-Min Cheng5Chih-Fan Yeh6Yen-Hung Lin7Hsin-Hsi Tsai8Department of Neurology, National Taiwan University Hospital Hsinchu Branch, Hsin-Chu, Taiwan; Department of Neurology, National Taiwan University Hospital, Taipei, TaiwanDepartment of Neurology, National Taiwan University Hospital, Taipei, Taiwan; Department of Neurology, National Taiwan University Hospital Bei-Hu Branch, Taipei, TaiwanDepartment of Neurology, National Taiwan University Hospital, Taipei, TaiwanDepartment of Psychiatry, College of Medicine, National Cheng Kung University Hospital, National Cheng Kung University, Tainan, TaiwanDepartment of Family Medicine, College of Medicine and Hospital, National Taiwan University, Taipei, TaiwanPh.D. Program of Interdisciplinary Medicine (PIM), National Yang Ming Chiao Tung University College of Medicine, Taipei, Taiwan; Division of Faculty Development, Taipei Veterans General Hospital, Taiwan; Center for Evidence-based Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Public Health, National Yang Ming Chiao Tung University College of Medicine, Taipei, Taiwan; Institute of Health and Welfare Policy, National Yang Ming Chiao Tung University College of Medicine, Taipei, TaiwanDivision of Cardiology, Department of Internal Medicine and Cardiovascular Center, National Taiwan University Hospital, Taipei, TaiwanDivision of Cardiology, Department of Internal Medicine and Cardiovascular Center, National Taiwan University Hospital, Taipei, TaiwanDepartment of Neurology, National Taiwan University Hospital, Taipei, Taiwan; Corresponding author. Department of Neurology, National Taiwan University Hospital, No. 7, Chung-Shan South Road, Taipei, 100, Taiwan.Controlling hypertension has become an important issue in the elderly population in whom neurological comorbidities are highly prevalent. Most of the large-scale trials focusing on hypertension management in older populations have excluded patients with comorbid neurological disorders. However, this population requires special considerations, as the benefits of antihypertensive agents are mostly uncertain and there is a higher risk of adverse events. In this review article, we discuss current evidence regarding the management of elderly patients with hypertension and common neurological disorders, including stroke and neurodegenerative diseases.In elderly patient with a history of stroke, the blood pressure management strategy is generally similar to that for young patients, however the benefits of stroke prevention from blood pressure control are less significant. For patients with neurodegenerative disorders such as cognitive dysfunction and Parkinson's disease, achieving adequate blood pressure control may be beneficial in reducing cardiovascular risks, although the higher risk of adverse events from antihypertensive treatment may offset some of these benefits. Special considerations for factors such as orthostatic hypotension, risk of falls, polypharmacy, and significant drug-drug interactions are required but frequently neglected in clinical practice. More efforts are warranted to determine the optimal treatment strategy for elderly populations with neurological disorders.http://www.sciencedirect.com/science/article/pii/S0929664625000087Blood pressureStrokeDementiaParkinson's disease
spellingShingle Cheng-Hsuan Li
Sung-Ju Hsueh
Li-Kai Tsai
Wei-Hung Chang
Shao-Yi Cheng
Hao-Min Cheng
Chih-Fan Yeh
Yen-Hung Lin
Hsin-Hsi Tsai
Blood pressure targets, medication considerations and special concerns in elderly hypertension III: Focus on stroke and neurodegenerative disorders
Journal of the Formosan Medical Association
Blood pressure
Stroke
Dementia
Parkinson's disease
title Blood pressure targets, medication considerations and special concerns in elderly hypertension III: Focus on stroke and neurodegenerative disorders
title_full Blood pressure targets, medication considerations and special concerns in elderly hypertension III: Focus on stroke and neurodegenerative disorders
title_fullStr Blood pressure targets, medication considerations and special concerns in elderly hypertension III: Focus on stroke and neurodegenerative disorders
title_full_unstemmed Blood pressure targets, medication considerations and special concerns in elderly hypertension III: Focus on stroke and neurodegenerative disorders
title_short Blood pressure targets, medication considerations and special concerns in elderly hypertension III: Focus on stroke and neurodegenerative disorders
title_sort blood pressure targets medication considerations and special concerns in elderly hypertension iii focus on stroke and neurodegenerative disorders
topic Blood pressure
Stroke
Dementia
Parkinson's disease
url http://www.sciencedirect.com/science/article/pii/S0929664625000087
work_keys_str_mv AT chenghsuanli bloodpressuretargetsmedicationconsiderationsandspecialconcernsinelderlyhypertensioniiifocusonstrokeandneurodegenerativedisorders
AT sungjuhsueh bloodpressuretargetsmedicationconsiderationsandspecialconcernsinelderlyhypertensioniiifocusonstrokeandneurodegenerativedisorders
AT likaitsai bloodpressuretargetsmedicationconsiderationsandspecialconcernsinelderlyhypertensioniiifocusonstrokeandneurodegenerativedisorders
AT weihungchang bloodpressuretargetsmedicationconsiderationsandspecialconcernsinelderlyhypertensioniiifocusonstrokeandneurodegenerativedisorders
AT shaoyicheng bloodpressuretargetsmedicationconsiderationsandspecialconcernsinelderlyhypertensioniiifocusonstrokeandneurodegenerativedisorders
AT haomincheng bloodpressuretargetsmedicationconsiderationsandspecialconcernsinelderlyhypertensioniiifocusonstrokeandneurodegenerativedisorders
AT chihfanyeh bloodpressuretargetsmedicationconsiderationsandspecialconcernsinelderlyhypertensioniiifocusonstrokeandneurodegenerativedisorders
AT yenhunglin bloodpressuretargetsmedicationconsiderationsandspecialconcernsinelderlyhypertensioniiifocusonstrokeandneurodegenerativedisorders
AT hsinhsitsai bloodpressuretargetsmedicationconsiderationsandspecialconcernsinelderlyhypertensioniiifocusonstrokeandneurodegenerativedisorders